Laraway Financial Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$359K Hold
1,512
0.22% 104
2026
Q1
$319K Sell
1,512
-314
-17% -$67.6K 0.22% 102
2025
Q4
$375K Hold
1,826
0.24% 90
2025
Q3
$287K Sell
1,826
-5
-0.3% -$772 0.2% 110
2025
Q2
$308K Buy
1,831
+1
+0.1% +$148 0.23% 97
2025
Q1
$252K Hold
1,830
0.2% 104
2024
Q4
$216K Buy
1,830
+1
+0.1% +$117 0.17% 112
2024
Q3
$202K Buy
1,829
+1
+0.1% +$105 0.16% 113
2024
Q2
$180K Hold
1,828
0.15% 109
2024
Q1
$205K Buy
+1,828
New +$197K 0.18% 108

Other funds holding CAH

Laraway Financial Advisors's CAH Position: Q2 2026 in Review

Laraway Financial Advisors held its Cardinal Health (CAH) position steady in Q2 2026 at 1,512 shares worth $359K. The position accounts for 0.22% of the portfolio, ranked #104.

Laraway Financial Advisors first reported a position in CAH in Q1 2024 and has held it in 10 quarters since. The position peaked at $375K in Q4 2025. 1,499 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Laraway Financial Advisors held 1,512 shares of Cardinal Health worth $359K as of Q2 2026.
  • Laraway Financial Advisors left its Cardinal Health share count unchanged in Q2 2026.
  • Cardinal Health made up 0.22% of Laraway Financial Advisors's portfolio in Q2 2026, its #104 holding.
  • Laraway Financial Advisors first reported a position in Cardinal Health in Q1 2024 and has held it in 10 quarters since.
  • Laraway Financial Advisors's Cardinal Health position peaked at $375K in Q4 2025.
  • 1,499 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Laraway Financial Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.